cancer Antibody
cancer Antibody
![]() Breast cancer |
|||
BR1008b | TissueArray | each | 306 EUR |
Description: Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM, clinical stage, and ER/PR/Her2 result, 100 cases/100 cores, replacing BR1008a |
|||
![]() Breast cancer |
|||
BR724 | TissueArray | each | 270 EUR |
Description: Breast cancer, adjacent and adjacent normal tissue array, 66 cases/72 cores |
|||
![]() Breast cancer |
|||
BR725 | TissueArray | each | 270 EUR |
Description: Breast cancer, adjacent and adjacent normal tissue array, 68 cases/72 cores |
|||
![]() Colorectal cancer |
|||
CRM1501 | TissueArray | each | 420 EUR |
Description: Colorectal cancer, 150 cases. |
|||
![]() Esophagus cancer |
|||
ES1041 | TissueArray | each | 306 EUR |
Description: Esophagus cancer, cancer adjacent and normal esophagus tissue array, including squamous cell carcinoma,adenocarcinoma,undifferentiated carcinoma, AT and normal tissue, pathology grade, TNM and clinical stage (AJCC 8.0), 104 cases/104 cores (core size 1.5mm), replacing ES1021 |
|||
![]() Lung cancer |
|||
LC751 | TissueArray | each | 234 EUR |
Description: Lung cancer, matched cancer adjacent and normal adjacent lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 25 cases/75 cores (core size 1.5mm),Recent Year Collection |
|||
![]() Prostate cancer |
|||
PR632 | TissueArray | each | 306 EUR |
Description: Prostate cancer, hyperplasia with normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 21cases/63 cores |
|||
![]() Stomach cancer |
|||
ST1451a | TissueArray | each | 540 EUR |
Description: Stomach cancer, matched NAT, matched metastasis tissue (recent year collection samples), including pathology grade, TNM and clinical stage, 71 cases/145 cores, replacing ST1451 |
|||
![]() Human Cancer Antigen CA125 (Ovarian Cancer) Protein |
|||
abx061590-100kU | Abbexa | 100 kU | 1446 EUR |
![]() Colon cancer and lung cancer tissue array |
|||
CLC601 | TissueArray | each | 306 EUR |
Description: Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores |
|||
![]() Stomach cancer and lung cancer tissue array |
|||
SLC601 | TissueArray | each | 306 EUR |
Description: Stomach cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores |
|||
![]() Colon cancer with cancer adjacent tissue array |
|||
T051b | TissueArray | each | 48 EUR |
Description: Colon cancer with cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T051a |
|||
![]() Cancer Susceptibility 3 (CASC3) Antibody |
|||
20-abx004578 | Abbexa |
|
|
![]() Cancer-Associated Nucleoprotein (CANP) Antibody |
|||
20-abx121462 | Abbexa |
|
|
![]() Cancer Susceptibility 3 (CASC3) Antibody |
|||
20-abx111351 | Abbexa |
|
|
![]() Cancer Antigen CA19-9 Antibody |
|||
abx020532-1mg | Abbexa | 1 mg | 1296 EUR |
![]() Cancer Antigen CA19-9 Antibody |
|||
abx020533-1mg | Abbexa | 1 mg | 718.8 EUR |
![]() Cancer Antigen CA19-9 Antibody |
|||
abx020534-1mg | Abbexa | 1 mg | 718.8 EUR |
![]() Cancer Antigen CA19-9 Antibody |
|||
abx020535-1mg | Abbexa | 1 mg | 718.8 EUR |
![]() Cancer Susceptibility 3 (CASC3) Antibody |
|||
abx033281-400ul | Abbexa | 400 ul | 627.6 EUR |
![]() Cancer Susceptibility 3 (CASC3) Antibody |
|||
abx033281-80l | Abbexa | 80 µl | 343.2 EUR |
![]() Cancer Susceptibility 3 (CASC3) Antibody |
|||
abx025070-400ul | Abbexa | 400 ul | 627.6 EUR |
![]() Cancer Susceptibility 3 (CASC3) Antibody |
|||
abx025070-80l | Abbexa | 80 µl | 343.2 EUR |
![]() Cancer Susceptibility 3 (CASC3) Antibody |
|||
abx235220-100ug | Abbexa | 100 ug | 577.2 EUR |
![]() Cancer Susceptibility 3 (CASC3) Antibody |
|||
20-abx213746 | Abbexa |
|
|
![]() Cancer Susceptibility 3 (CASC3) Antibody |
|||
20-abx214020 | Abbexa |
|
|
![]() Liver cancer antibody screening array |
|||
LV1001 | TissueArray | each | 306 EUR |
Description: Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases/100 cores |
|||
![]() Kidney cancer tissue array with matched cancer adjacent and cancer kidney adjacent tissue |
|||
KD991b | TissueArray | each | 270 EUR |
Description: Kidney cancer tissue array with matched cancer adjacent and cancer kidney adjacent tissue, 33 cases/ 99 cores, replacing KD991a |
|||
![]() Human Cancer PrimaCell15: Skin Cancer Cells Growth Medium |
|||
9-46038 | CHI Scientific | 5 x 100 ml | Ask for price |
![]() Breast cancer with cancer adjacent breast tissue array |
|||
BC081116e | TissueArray | each | 306 EUR |
Description: Breast cancer with cancer adjacent breast tissue array, including invasive carcinoma of no special type, breast carcinoma with apocrine differentiation and AT tissue,pat hology grade, IHC (ER/PR/Her-2/Ki67) info, TNM/Stage (AJCC 7th edition), 107 cases/110 cores (core size 1.5mm), replacing BC081116d |
|||
![]() Cervix cancer tissue array with cancer adjacent tissue |
|||
CR501a | TissueArray | each | 234 EUR |
Description: Cervix cancer tissue array with cancer adjacent tissue, including TNM, clinical stage and pathology grade, 50 cases/50 cores, replacing CR501 |
|||
![]() Pancreatic cancer tissue array with cancer adjacent tissue |
|||
PA242e | TissueArray | each | 66 EUR |
Description: Pancreatic cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing PA242d |
|||
![]() Prostate cancer tissue array with cancer adjacent tissues |
|||
PR721 | TissueArray | each | 306 EUR |
Description: Prostate cancer tissue array with cancer adjacent tissues, including WHO grade, gleason grade, gleason score, TNM and stage info, 24 cases/72 cores |
|||
![]() Stomach cancer with matched cancer adjacent tissue array |
|||
ST1504 | TissueArray | each | 258 EUR |
Description: Stomach cancer with matched cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores |
|||
![]() Breast cancer TMA |
|||
BR602 | TissueArray | each | 270 EUR |
Description: Breast cancer TMA, 3 samples have matched cancer adjacent tissue samples, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 57 cases/60 cores (Core Size 1.5mm), recent tear collections |
|||
![]() Kidney cancer (CCRCC |
|||
KD1201 | TissueArray | each | 306 EUR |
Description: Kidney cancer (CCRCC,PRCC,CRCC)with kidney tissue array,including ISUP Grade, TNM/Stage, 120 cases/120 cores (core size 1.0mm ), (Previous Item# is BC07115b) |
|||
![]() Small intestine cancer |
|||
SM208 | TissueArray | each | 546 EUR |
Description: Small intestine cancer, metastatic lymph nodes and normal tissue high density tissue microarray, 69 cases/208 core, with stage and grade data |
|||
![]() Cancer/testis Antigen 2 (CTAG2) Antibody |
|||
20-abx149592 | Abbexa |
|
|
![]() Cancer/Testis Antigen 1B (CTAG1B) Antibody |
|||
20-abx171540 | Abbexa |
|
|
![]() Cancer/Testis Antigen 1B (CTAG1B) Antibody |
|||
20-abx135754 | Abbexa |
|
|
![]() Cancer/Testis Antigen 5.1 (SSX1) Antibody |
|||
abx145140-100ug | Abbexa | 100 ug | 469.2 EUR |
![]() Oral Cancer Overexpressed 1 (ORAOV1) Antibody |
|||
20-abx007927 | Abbexa |
|
|
![]() Bladder Cancer-Associated Protein (BLCAP) Antibody |
|||
20-abx119060 | Abbexa |
|
|
![]() Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
20-abx126874 | Abbexa |
|
|
![]() Cancer/Testis Antigen 1B (CTAG1B) Antibody |
|||
20-abx128209 | Abbexa |
|
|
![]() Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
20-abx111352 | Abbexa |
|
|
![]() Oral Cancer Overexpressed 1 (ORAOV1) Antibody |
|||
20-abx013722 | Abbexa |
|
|
![]() Cancer Antigen CA 19-9 Antibody |
|||
abx023798-1mg | Abbexa | 1 mg | 1053.6 EUR |
![]() Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
abx027441-400ul | Abbexa | 400 ul | 627.6 EUR |
![]() Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
abx027441-80l | Abbexa | 80 µl | 343.2 EUR |
![]() Cancer/testis Antigen 2 (CTAG2) Antibody |
|||
abx027593-400ul | Abbexa | 400 ul | 627.6 EUR |
![]() Cancer/testis Antigen 2 (CTAG2) Antibody |
|||
abx027593-80l | Abbexa | 80 µl | 343.2 EUR |
![]() Oral Cancer Overexpressed 1 (ORAOV1) Antibody |
|||
abx331088-100ul | Abbexa | 100 ul | 510 EUR |
![]() Cancer/Testis Antigen 1A (CTAG1A) Antibody |
|||
abx331930-100ul | Abbexa | 100 ul | 510 EUR |
![]() Cancer/Testis Antigen 5.1 (SSX1) Antibody |
|||
20-abx302290 | Abbexa |
|
|
![]() Cancer/Testis Antigen 5.1 (SSX1) Antibody |
|||
20-abx323587 | Abbexa |
|
|
![]() Oral Cancer Overexpressed 1 (ORAOV1) Antibody |
|||
20-abx324804 | Abbexa |
|
|
![]() Bladder Cancer-Associated Protein (BLCAP) Antibody |
|||
20-abx326375 | Abbexa |
|
|
![]() Cancer/Testis Antigen 5.1 (SSX1) Antibody |
|||
abx238257-100ug | Abbexa | 100 ug | 661.2 EUR |
![]() Urinary Bladder Cancer Antigen (UBC) Antibody |
|||
abx239152-100ug | Abbexa | 100 ug | 610.8 EUR |
![]() Anti-Breast Cancer Resistance Protein antibody |
|||
STJ16100903 | St John's Laboratory | 1 mL | 573.6 EUR |
![]() Anti-Breast Cancer Resistance Protein antibody |
|||
STJ16100916 | St John's Laboratory | 1 mL | 573.6 EUR |
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
R32468 | NSJ Bioreagents | 100 ug | 419 EUR |
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
V8435-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma. |
|||
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
V8435-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma. |
|||
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
V8435SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma. |
|||
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
V8645-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma. |
|||
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
V8645-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma. |
|||
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
V8645SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma. |
|||
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
V8877-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: AMACR, also known as p504S, is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma. |
|||
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
V8877-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: AMACR, also known as p504S, is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma. |
|||
![]() AMACR / p504S Antibody (Prostate Cancer Marker) |
|||
V8877SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: AMACR, also known as p504S, is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma. |